Tyler Shugg

11PUBLICATIONS

22CO-AUTHORS

PharmacogenomicsWastewater treatment processesMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Medical molecular engineering of nucleic acids and proteins

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 08, 2026

How Drug-Drug Interaction Studies Inform Drug Labeling: A Survey of US Food and Drug Administration-Approved New Molecular Entities from 1998 to 2022.

|Mar 07, 2026

Pharmacokinetic Drug-Drug Interaction Potential of Oral Anticancer Drugs.

Fatimah Alhurayri, Islam R Younis, Shadia I Jalal

|Feb 09, 2026

Cohort Study to Determine the Impact of CYP3A5 Genotype on Tacrolimus Dosing Requirements and Trough Concentrations in Heart Transplant Recipients.

Yanting Wu, Michael T Eadon, Laurie Schenkelberg

|Jul 25, 2025

Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors.

Darius Meiman, Todd C Skaar, Tyler Shugg

|May 12, 2025

Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y<sub>12</sub> Inhibitor Prescribing.

Ashley N Springer, Leah A Alicea, Yemi Gafari

|Jan 10, 2025

Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs.

Hyunwoo Koo, Tayler B Smith, John T Callaghan

Pageof 2

Frequent Collaborators

Todd C Skaar

Emma M Tillman

John T Callaghan

Islam R Younis

Reynold C Ly

Michael T Eadon

Ashley N Springer

Jennelle C Hodge

Victoria M Pratt

Nicholas R Powell

Frequent Collaborators

Todd C Skaar

Emma M Tillman

John T Callaghan

Islam R Younis